Literature DB >> 21835910

Hyperphosphorylation of mouse cardiac titin contributes to transverse aortic constriction-induced diastolic dysfunction.

Bryan Hudson1, Carlos Hidalgo, Chandra Saripalli, Henk Granzier.   

Abstract

RATIONALE: Mechanisms underlying diastolic dysfunction need to be better understood.
OBJECTIVE: To study the role of titin in diastolic dysfunction using a mouse model of experimental heart failure induced by transverse aortic constriction. METHODS AND
RESULTS: Eight weeks after transverse aortic constriction surgery, mice were divided into heart failure (HF) and congestive heart failure (CHF) groups. Mechanical studies on skinned left ventricle myocardium measured total and titin-based and extracellular matrix-based passive stiffness. Total passive stiffness was increased in both HF and CHF mice, and this was attributable to increases in both extracellular matrix-based and titin-based passive stiffness, with titin being dominant. Protein expression and titin exon microarray analysis revealed increased expression of the more compliant N2BA isoform at the expense of the stiff N2B isoform in HF and CHF mice. These changes are predicted to lower titin-based stiffness. Because the stiffness of titin is also sensitive to titin phosphorylation by protein kinase A and protein kinase C, back phosphorylation and Western blot assays with novel phospho-specific antibodies were performed. HF and CHF mice showed hyperphosphorylation of protein kinase A sites and the proline glutamate valine lysine (PEVK) S26 protein kinase C sites, but hypophosphorylation of the PEVK S170 protein kinase C site. Protein phosphatase I abolished differences in phosphorylation levels and normalized titin-based passive stiffness levels between control and HF myocardium.
CONCLUSION: Transverse aortic constriction-induced HF results in increased extracellular matrix-based and titin-based passive stiffness. Changes in titin splicing occur, which lower passive stiffness, but this effect is offset by hyperphosphorylation of residues in titin spring elements, particularly of PEVK S26. Thus, complex changes in titin occur that combined are a major factor in the increased passive myocardial stiffness in HF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835910      PMCID: PMC3191198          DOI: 10.1161/CIRCRESAHA.111.246819

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  41 in total

1.  Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium.

Authors:  Sunshine Lahmers; Yiming Wu; Douglas R Call; Siegfried Labeit; Henk Granzier
Journal:  Circ Res       Date:  2004-01-05       Impact factor: 17.367

2.  Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.

Authors:  Sherif F Nagueh; Gopi Shah; Yiming Wu; Guillermo Torre-Amione; Nicholas M P King; Sunshine Lahmers; Christian C Witt; Katy Becker; Siegfried Labeit; Henk L Granzier
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

3.  Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments.

Authors:  H L Granzier; T C Irving
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

4.  Exercise training does not improve cardiac function in compensated or decompensated left ventricular hypertrophy induced by aortic stenosis.

Authors:  Elza D van Deel; Martine de Boer; Diederik W Kuster; Nicky M Boontje; Patricia Holemans; Karin R Sipido; Jolanda van der Velden; Dirk J Duncker
Journal:  J Mol Cell Cardiol       Date:  2011-02-01       Impact factor: 5.000

5.  The influence of basic residues on the substrate specificity of protein kinase C.

Authors:  C House; R E Wettenhall; B E Kemp
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

6.  Titin isoform switch in ischemic human heart disease.

Authors:  Ciprian Neagoe; Michael Kulke; Federica del Monte; Judith K Gwathmey; Pieter P de Tombe; Roger J Hajjar; Wolfgang A Linke
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

7.  Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.

Authors:  I Makarenko; C A Opitz; M C Leake; C Neagoe; M Kulke; J K Gwathmey; F del Monte; R J Hajjar; W A Linke
Journal:  Circ Res       Date:  2004-09-02       Impact factor: 17.367

8.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

Authors:  Michael R Zile; Catalin F Baicu; William H Gaasch
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

9.  Titin isoform expression in normal and hypertensive myocardium.

Authors:  Chad M Warren; Maria C Jordan; Kenneth P Roos; Paul R Krzesinski; Marion L Greaser
Journal:  Cardiovasc Res       Date:  2003-07-01       Impact factor: 10.787

Review 10.  What mechanisms underlie diastolic dysfunction in heart failure?

Authors:  David A Kass; Jean G F Bronzwaer; Walter J Paulus
Journal:  Circ Res       Date:  2004-06-25       Impact factor: 17.367

View more
  32 in total

Review 1.  Titin is a major human disease gene.

Authors:  Martin M LeWinter; Henk L Granzier
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

2.  Residual force enhancement is regulated by titin in skeletal and cardiac myofibrils.

Authors:  Nabil Shalabi; Anabelle Cornachione; Felipe de Souza Leite; Srikar Vengallatore; Dilson E Rassier
Journal:  J Physiol       Date:  2017-02-19       Impact factor: 5.182

Review 3.  Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?

Authors:  Valentine Prat; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 4.  Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium.

Authors:  Francesco S Loffredo; Andriana P Nikolova; James R Pancoast; Richard T Lee
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 5.  Tuning the molecular giant titin through phosphorylation: role in health and disease.

Authors:  Carlos Hidalgo; Henk Granzier
Journal:  Trends Cardiovasc Med       Date:  2013-01-05       Impact factor: 6.677

6.  Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.

Authors:  Kirk R Hutchinson; Chandra Saripalli; Charles S Chung; Henk Granzier
Journal:  J Mol Cell Cardiol       Date:  2014-11-08       Impact factor: 5.000

Review 7.  Cardiac titin and heart disease.

Authors:  Martin M LeWinter; Henk L Granzier
Journal:  J Cardiovasc Pharmacol       Date:  2014-03       Impact factor: 3.105

8.  Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome.

Authors:  Coen A C Ottenheijm; Nicol C Voermans; Bryan D Hudson; Thomas Irving; Ger J M Stienen; Baziel G van Engelen; Henk Granzier
Journal:  J Appl Physiol (1985)       Date:  2012-01-05

9.  The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements.

Authors:  Carlos G Hidalgo; Charles S Chung; Chandra Saripalli; Mei Methawasin; Kirk R Hutchinson; George Tsaprailis; Siegfried Labeit; Alicia Mattiazzi; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2012-12-05       Impact factor: 5.000

10.  Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction.

Authors:  Hao Tang; Kunhong Xiao; Lan Mao; Howard A Rockman; Douglas A Marchuk
Journal:  J Mol Cell Cardiol       Date:  2012-10-16       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.